The project was supported by: (a) the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH), under award number R01HL122154 (PI: JSK)
All compounded BPC-157 must be labeled: "Compounded by an FDA-registered pharmacy
It stimulates collagen production in dermal fibroblasts by up to 70% at optimal concentrations around 1 nanomolar
Luteolin increases the sucrose preference of mice, decreases immobility time in the FST, and inhibits IL-1 and IL-6 production in mouse brains
It is supplied as a filler-free lyophilized powder and reconstituted with a sterile solvent immediately before experimental use
Provider Comparisons Compare BPC-157 and GHK-Cu peptides: healing mechanisms, clinical efficacy, side effects, and costs